Scientists Take Another Step Toward Creating an HIV Vaccine

Article

The scientific group of Peter the Great St. Petersburg Polytechnic University headed by professor Andrei Kozlov published the results of a study devoted to the search of solutions for creating the HIV vaccine.

During two years, with the support of the Russian Science Foundation's grant, researchers studied features of transmitted variants of HIV-1 virus. This type of HIV transmission is most typical for Russian Federation.

Within the framework of the project, scientists have studied blood samples of injecting drug users with acute or early stages of HIV infection. The transmission of only one viral variant was detected in 70 percent of cases. These data were obtained by the method of single genome analysis (SGA), which allows to analyze 20-30 single genomes. In addition, the scientific group used the next-generation sequencing approach (NGS), capable of analyzing up to 5000 genomes. Thus, scientists managed to establish that all viruses are the "descendants" of any one virus particle. This phenomenon is called the genetic bottleneck effect. The research results are described in the article "Characterization of the Transmitted Virus in an Ongoing HIV-1 Epidemic Driven by Injecting Drug Use" published in the journal AIDS Research and Human Retroviruses.

"Though this work is fundamental, we are working with the genes of the viruses, which can be used in design of vaccine against HIV. So to speak, it is necessary to create the vaccine not against all possible viruses, but against those which are transmitted and cause the infection. We will use these data in the further work on HIV vaccine development," notes Kozlov.

Source: Peter the Great St. Petersburg Polytechnic University

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content